Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-16 Sale | 2024-04-18 5:12 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 48,124 | $7.6263 | $367,007 | 4,447,837 (Direct) | View |
| 2024-03-12 Sale | 2024-03-14 7:28 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $10.74 | $537,190 | 4,570,961 (Direct) | View |
| 2024-02-13 Sale | 2024-02-15 6:00 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $10.16 | $507,985 | 4,703,133 (Direct) | View |
| 2024-01-16 Sale | 2024-01-18 6:37 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $10.35 | $517,508 | 4,299,416 (Direct) | View |
| 2023-12-12 Sale | 2023-12-14 6:53 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $7.4928 | $374,638 | 4,424,416 (Direct) | View |
| 2023-11-14 Sale | 2023-11-16 6:54 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $6.8186 | $340,929 | 4,549,416 (Direct) | View |
| 2023-10-10 Sale | 2023-10-12 6:07 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $6.9615 | $348,075 | 4,681,588 (Direct) | View |
| 2023-09-12 Sale | 2023-09-14 6:26 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $8.559 | $427,950 | 4,806,588 (Direct) | View |
| 2023-08-15 Sale | 2023-08-17 6:35 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $9.0862 | $454,310 | 4,969,088 (Direct) | View |
| 2023-07-18 Sale | 2023-07-19 7:07 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $14.58 | $729,150 | 4,246,494 (Direct) | View |
| 2023-06-13 Sale | 2023-06-15 7:28 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 50,000 | $10 | $500,145 | 4,371,494 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-16 Exercise | 2024-04-18 5:12 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,447,837 (Direct) | View |
| 2024-04-16 Exercise | 2024-04-18 5:12 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,447,837 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-14 7:28 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,570,961 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-14 7:28 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,570,961 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-16 7:59 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 7,172 | $12.43 | 1,179,179 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 6:00 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,703,133 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 6:00 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,703,133 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-13 7:01 pm | N/A 2034-02-09 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 531,229 | $0 | 3,755,498 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 7:01 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 2,512 | $10.09 | 3,755,498 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 6:37 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,299,416 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 6:37 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,299,416 (Direct) | View |
| 2023-12-12 Exercise | 2023-12-14 6:53 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,424,416 (Direct) | View |
| 2023-12-12 Exercise | 2023-12-14 6:53 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,424,416 (Direct) | View |
| 2023-11-15 Tax Withholding | 2023-11-16 6:54 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 7,172 | $7.18 | 4,549,416 (Direct) | View |
| 2023-11-14 Exercise | 2023-11-16 6:54 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,549,416 (Direct) | View |
| 2023-11-14 Exercise | 2023-11-16 6:54 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,549,416 (Direct) | View |
| 2023-10-10 Exercise | 2023-10-12 6:07 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,681,588 (Direct) | View |
| 2023-10-10 Exercise | 2023-10-12 6:07 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,681,588 (Direct) | View |
| 2023-09-12 Exercise | 2023-09-14 6:26 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,806,588 (Direct) | View |
| 2023-09-12 Exercise | 2023-09-14 6:26 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,806,588 (Direct) | View |
| 2023-08-15 Exercise | 2023-08-17 6:35 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,969,088 (Direct) | View |
| 2023-08-15 Exercise | 2023-08-17 6:35 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,969,088 (Direct) | View |
| 2023-08-15 Tax Withholding | 2023-08-17 6:35 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 4,727 | $9.19 | 4,969,088 (Direct) | View |
| 2023-07-18 Exercise | 2023-07-19 7:07 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,246,494 (Direct) | View |
| 2023-07-18 Exercise | 2023-07-19 7:07 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,246,494 (Direct) | View |
| 2023-06-13 Exercise | 2023-06-15 7:28 pm | N/A 2030-03-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $0 | 4,371,494 (Direct) | View |
| 2023-06-13 Exercise | 2023-06-15 7:28 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 75,000 | $2.22 | 4,371,494 (Direct) | View |
| 2023-05-15 Tax Withholding | 2023-05-17 6:17 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 4,760 | $5.6 | 790,159 (Direct) | View |
| 2022-02-04 Tax Withholding(A) | 2023-04-28 4:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 678 | $11.4 | 590,380 (Direct) | View |
| 2022-02-04 Option Award(A) | 2023-04-28 4:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 60,299 | $0 | 590,380 (Direct) | View |
| 2023-02-15 Tax Withholding | 2023-02-17 5:15 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 1,258 | $8.44 | 794,310 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 5:14 pm | N/A 2033-02-01 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 615,020 | $0 | 1,200,425 (Direct) | View |
| 2023-02-01 Tax Withholding | 2023-02-03 5:14 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 2,669 | $8.55 | 1,200,425 (Direct) | View |
| 2022-11-15 Tax Withholding | 2022-11-17 6:45 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 1,065 | $11.86 | 586,572 (Direct) | View |
| 2022-08-15 Tax Withholding | 2022-08-17 6:33 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 1,065 | $12.96 | 587,637 (Direct) | View |
| 2022-05-16 Tax Withholding | 2022-05-18 7:17 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 1,069 | $5.67 | 588,702 (Direct) | View |
| 2022-02-04 Tax Withholding | 2022-02-08 9:07 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 678 | $11.4 | 3,030,682 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-08 9:07 pm | N/A 2032-02-04 | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 180,897 | $0 | 3,030,682 (Direct) | View |
| 2021-04-20 Conversion | 2021-04-22 8:09 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 4,789,703 | $0 | 3,906,599 (Direct) | View |
| 2021-04-20 Other | 2021-04-22 8:09 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 528,762 | $0 | 3,906,599 (Direct) | View |
Ownership | 2021-04-15 09:02 am | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer | 0 | $0 | 2,849,075 (Direct) | View |